Gland Pharma Limited — Important, 11-07-2025: General Updates
11-07-2025 | 04:01 pm
11-07-2025 | 04:01 pm
Gland Pharma’s Pashamylaram facility has received GMP Compliance Certification from the Danish Medicines Agency for aseptically prepared powders used in injection, infusion, and inhalation. This certification supports the company’s ability to supply regulated European markets, potentially boosting export opportunities and strengthening its global manufacturing credentials.
No comments yet. Be the first to comment!
